March 29, 2025 05:17 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Telangana man marries two women in same ceremony after falling in love with both | Vladimir Putin says Russia won't interfere in Donald Trump's plans to 'take over' Greenland | India ready to offer possible assistance: PM Modi on Myanmar, Thailand earthquake | Magnitude 7.7 Earthquake hits Myanmar, strong tremors felt in Bangkok | 'Complete lawlessness': Suvendu Adhikari writes to Bengal Guv over Malda violence | 'You are a liar': Mamata Banerjee faces guests' ire over Singur, RG Kar, 'attack on Hindus' at London event | 3 cops killed, 2 terrorists shot dead during J&K's Kathua encounter: Report | Kolkata couple sues IVF centre for not revealing daughter's biological parents' identity, blames it for her death | 'India is not Dharamshala', Amit Shah says as Lok Sabha passes Immigration and Foreigners Bill 2025 | 'Now it's our turn': Vladimir Putin accepts Narendra Modi's invitation to visit India
Canada
Image credit: Wikimedia Commons

Health Canada approves Moderna’s updated COVID-19 vaccine for Omicron variant

| @indiablooms | Sep 03, 2022, at 05:03 am

Toronto/IBNS: Moderna’s updated COVID-19 vaccine targeting the Omicron variant has been formally approved by Health Canada.

This vaccine has been approved for use in adults and will become the first COVID-19 vaccine available in Canada that targets Omicron in addition to the original strain of the coronavirus.

Health Canada said in a decision summary made public Thursday, that the new vaccine shows “significantly higher responses” to the Omicron BA.1 virus in comparison to Moderna’s original coronavirus vaccine, officially branded as Spikevax.

Although the updated vaccine was developed to target the Omicron BA.1 variant, clinical trials, says Health Canada suggest the new vaccine still shows a stronger immune response against the more recent mutations of Omicron — BA.4 and BA.5 — which are now dominant.

According to recommendations of the National Advisory Committee on Immunization (NACI) the updated vaccine should be offered to adults who are recommended to receive a fall booster dose.

NACI says that the vaccine could also be offered to adolescents between 12 and 17 with “moderately to severely immunocompromising conditions” and those who have elevated social risk factors.

(Reporting by Asha Bajaj)

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu